Listed

Chemed Corp: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Nov 1, 2013 and accepted by EDGAR at Nov 1, 2013, 08:22 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-07-01 to 2013-09-30$340.9mus-gaap:SalesRevenueNet
Revenue9 months2013-01-01 to 2013-09-30$1.06bnus-gaap:SalesRevenueNet
Cost of revenue3 months2013-07-01 to 2013-09-30$243.2mus-gaap:CostOfRevenue
Cost of revenue9 months2013-01-01 to 2013-09-30$762.9mus-gaap:CostOfRevenue
Selling, general and administrative3 months2013-07-01 to 2013-09-30$48.9mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2013-01-01 to 2013-09-30$157.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2013-07-01 to 2013-09-30$29.2mus-gaap:OperatingIncomeLoss
Operating income9 months2013-01-01 to 2013-09-30$94.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-07-01 to 2013-09-30$3.5mus-gaap:InterestExpense
Interest expense9 months2013-01-01 to 2013-09-30$11.3mus-gaap:InterestExpense
Income tax3 months2013-07-01 to 2013-09-30$8.2mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-01-01 to 2013-09-30$31.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-07-01 to 2013-09-30$17.4mus-gaap:NetIncomeLoss
Net income9 months2013-01-01 to 2013-09-30$54.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-07-01 to 2013-09-30$0.94us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30$2.89us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-07-01 to 2013-09-30$0.96us-gaap:EarningsPerShareBasic
Basic EPS9 months2013-01-01 to 2013-09-30$2.95us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-07-01 to 2013-09-3018,522,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2013-01-01 to 2013-09-3018,824,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2013-01-01 to 2013-09-30$135.9mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2013-01-01 to 2013-09-30$18.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2013-01-01 to 2013-09-30$10.5mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2013-01-01 to 2013-09-30$89.6mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2013-09-30$83.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-09-30$216.4mus-gaap:AssetsCurrent
Total assetsAt period end2013-09-30$881.5mus-gaap:Assets
Current liabilitiesAt period end2013-09-30$376.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-09-30$454.7mus-gaap:Liabilities
Current portion of debtAt period end2013-09-30$181.3mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2013-09-30$426.8mus-gaap:StockholdersEquity
Shares outstandingAt period end2013-09-3017,634,176 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001157523-13-005200. Last ingested by Listed: Nov 14, 2026, 12:29 ET. Listed shows no prices and gives no investment advice.